Pharmacodynamic effects of clopidogrel in pediatric cardiac patients: A comparative study of platelet aggregation response

Platelets

Volumn 23, Issue 6, 2012, Pages 430-438

  Jennings, Lisa K ^a   Michelson, Alan D ^b   Jacoski, Mary V ^a   Tyagi, Aditya ^a   Grgurevich, Svetozar ^a   Li, Jennifer S ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

congenital; Heart defects; Pediatrics; Platelet aggregation; Platelet inhibitors

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOPIDOGREL; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT RESPONSE;

ADENOSINE DIPHOSPHATE; ADULT; ARTERIES; BLOOD PLATELETS; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; FETAL BLOOD; HEART; HEART DISEASES; HUMANS; INFANT; INFANT, NEWBORN; MALE; PEPTIDE FRAGMENTS; PLACEBOS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; THROMBOSIS; TICLOPIDINE;

EID: 84864848842     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.650244     Document Type: Article

References (32)

1. Ts'ao CH. Comparable inhibition of aggregation of PRP of neonates and adults by aspirin. Haemostasis 1977;6:118-126.
2. Louden KA, Broughton Pipkin F, Heptinstall S, Fox SC, Tuohy P, O'Callaghan C, Mitchell JR, Symonds EM. Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: The effect of maternal low dose aspirin. Br J Obstet Gynaecol 1994;101:203-208.
3. Tanindi S, Kü rekçi AE, Köseoǧ lu V, Kurt M, Ozcan O. The normalization period of platelet aggregation in newborns. Thromb Res 1995;80:57-62.
4. Israels SJ, Odaibo FS, Robertson C, McMillan EM, McNicol A. Deficient thromboxane synthesis and response in platelets from premature infants. Pediatr Res 1997;41:218-223.
5. Uçar T, Gurman C, Arsan S, Kemahli S. Platelet aggregation in term and preterm newborns. Pediatr Hematol Oncol 2005;22:139-145.
6. Cvirn G, Kutschera J, Wagner T, Ferstl U, Vrecko K, Hallstrom S, Juergens G, Koestenberger M. Collagen/endogenous thrombin-induced platelet aggregation in cord versus adult whole blood. Neonatology 2009;95:187-192.
7. Strauss T, Sidlik-Muskatel R, Kenet G. Developmental hemostasis: Primary hemostasis and evaluation of platelet function in neonates. Semin Fetal Neonatal Med 2011;16(6):301-304.
8. Saxonhouse MA, Garner R, Mammel L, Li Q, Muller KE, Greywoode J, Miller C, Sola-Visner M. Closure times measured by the platelet function analyzer PFA-100 are longer in neonatal blood compared to cord blood samples. Neonatology 2010;97:242-249.
9. Gatti L, Guarneri D, Caccamo ML, Gianotti GA, Marini A. Platelet activation in newborns detected by flow-cytometry. Biol Neonate 1996;70:322-327.
10. Israels SJ, Daniels M, McMillan EM. Deficient collageninduced activation in the newborn platelet. Pediatr Res 1990;27:337-343.
11. Rajasekhar D, Barnard MR, Bednarek FJ, Michelson AD. Platelet hyporeactivity in very low birth weight neonates. Thromb Haemost 1997;77:1002-1007.
12. Rajasekhar D, Kestin AS, Bednarek FJ, Ellis PA, Barnard MR, Michelson AD. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 1994;72:957-963.
13. Heistein LC, Scott WA, Zellers TM, Fixler DE, Ramaciotti C, Journeycake JM, Lemler MS. Aspirin resistance in children with heart disease at risk for thromboembolism: Prevalence and possible mechanisms. Pediatr Cardiol 2008;29:285-291.
14. Yee DL, Dinu BR, Sun CW, Edwards RM, Justino H, Teruya J, Bray PF, Bomgaars L. Low prevalence and assay discordance of ''aspirin resistance'' in children. Pediatr Blood Cancer 2008;51:86-92.
15. Li JS, Yow E, Berezny KY, Bokesch PM, Takahashi M, Graham Jr TP, Sanders SP, Sidi D, Bonnet D, Ewert P, et al. Dosing of clopidogrel for platelet inhibition in infants and young children: Primary results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) trial. Circulation 2008;117:553-559.
16. Born GV, Cross MJ. The aggregation of blood platelets. J Physiol 1963;168:178-195.
17. Folie BJ, McIntire LV. Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow. Biophys J 1989;56:1121-1141.
18. Knö fler R, Weissbach G, Kuhlisch E. Platelet function tests in childhood. Measuring aggregation and release reaction in whole blood. Semin Thromb Hemost 1998;24:513-521.
19. Pietrucha T, Wojciechowski T, Greger J, Jd E, Nowak S, Chrul S, Golanski J, Watala C. Differentiated reactivity of whole blood neonatal platelets to various agonists. Platelets 2001;12:99-107.
20. Schlagenhauf A, Schweintzger S, Birner-Gruenberger R, Leschnik B, Muntean W. Newborn platelets: Lower levels of protease-activated receptors cause hypoaggregability to thrombin. Platelets 2010;21:641-647.
21. Hézard N, Potron G, Schlegel N, Amory C, Leroux B, Nguyen P. Unexpected persistence of platelet hyporeactivity beyond the neonatal period: A flow cytometric study in neonates, infants and older children. Thromb Haemost 2003;90:116-123.
22. von Beckerath N, Kastrati A, Wieczorek A, Pogatsa-Murray G, Sibbing D, Graf I, Schomig A. A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days. Eur Heart J 2007;28:1814-1819
23. Angiolillo DJ, Shoemaker SB, Desai B, Yuan H, Charlton RK, Bernardo E, Zenni MM, Guzman LA, Bass TA, Costa MA. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: Results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study. Circulation 2007;115:708-716.
24. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-2913.
25. Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J. Variability in responsiveness to clopidogrel in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2006;32:71-75.
26. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005;45:246-251.
27. Michelson AD, Linden MD, Furman MI, Li Y, Barnard MR, Fox ML, Lau WC, McLaughlin TJ, Frelinger AL. Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'. J Thromb Haemost 2007;5:75-81.
28. Serebruany V, Pokov I, Kuliczkowski W, Chesebro J, Badimon J. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease. Thromb Haemost 2008; 100:76-82.
29. Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin ''resistance'' and risk of cardiovascular morbidity: Systematic review and meta-analysis. BMJ 2008;336:195-198.
30. Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Jukema JW, Huisman MV. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis. Am Heart J 2007;154:221-231.
31. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 2009;360:354-362.
32. Geisler T, Schaeffeler E, Dippon J, Winter S, Buse V, Bischofs C, Zuern C, Moerike K, Gawaz M, Schwab M. CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation. Pharmacogenomics 2008;9:1251-1259.